Ami Fadia

Stock Analyst at Needham

(4.03)
# 576
Out of 5,024 analysts
394
Total ratings
47.91%
Success rate
12.85%
Average return

Stocks Rated by Ami Fadia

GH Research
Oct 13, 2025
Initiates: Buy
Price Target: $19
Current: $14.52
Upside: +30.85%
Atai Life Sciences
Oct 13, 2025
Initiates: Buy
Price Target: $12
Current: $5.96
Upside: +101.34%
Mind Medicine (MindMed)
Oct 13, 2025
Initiates: Buy
Price Target: $28
Current: $12.66
Upside: +121.17%
Immuneering
Sep 30, 2025
Reiterates: Buy
Price Target: $11
Current: $6.16
Upside: +78.57%
Merus
Sep 29, 2025
Downgrades: Hold
Price Target: $96
Current: $94.95
Upside: +1.11%
ACADIA Pharmaceuticals
Sep 24, 2025
Maintains: Buy
Price Target: $30$28
Current: $21.74
Upside: +28.79%
Harmony Biosciences Holdings
Sep 24, 2025
Maintains: Buy
Price Target: $48$41
Current: $26.63
Upside: +53.96%
Biogen
Sep 24, 2025
Reiterates: Hold
Price Target: n/a
Current: $143.66
Upside: -
Neurocrine Biosciences
Sep 22, 2025
Maintains: Buy
Price Target: $161$170
Current: $137.73
Upside: +23.43%
Revolution Medicines
Sep 11, 2025
Maintains: Buy
Price Target: $56$66
Current: $49.56
Upside: +33.17%
Reiterates: Buy
Price Target: $202
Current: $135.80
Upside: +48.75%
Maintains: Buy
Price Target: $18$16
Current: $7.78
Upside: +105.66%
Reiterates: Buy
Price Target: $150
Current: $129.58
Upside: +15.76%
Reiterates: Buy
Price Target: $45
Current: $32.23
Upside: +39.62%
Reiterates: Hold
Price Target: n/a
Current: $16.57
Upside: -
Reiterates: Buy
Price Target: $80
Current: $57.35
Upside: +39.49%
Initiates: Buy
Price Target: $35
Current: $22.59
Upside: +54.94%
Reiterates: Buy
Price Target: $5
Current: $1.84
Upside: +171.74%
Reiterates: Buy
Price Target: $19
Current: $15.16
Upside: +25.33%
Reiterates: Buy
Price Target: $29
Current: $8.39
Upside: +245.65%
Maintains: Outperform
Price Target: $240$320
Current: $19.92
Upside: +1,506.43%
Downgrades: Market Perform
Price Target: $63$75
Current: $23.45
Upside: +219.83%
Maintains: Market Perform
Price Target: $15$23
Current: $0.74
Upside: +2,950.02%
Maintains: Outperform
Price Target: $64$63
Current: $21.38
Upside: +194.67%
Upgrades: Market Perform
Price Target: n/a
Current: $19.78
Upside: -
Initiates: Outperform
Price Target: $22
Current: $1.35
Upside: +1,535.69%